...
首页> 外文期刊>Molecular Neurobiology >G-CSF-mobilized Bone Marrow Mesenchymal Stem Cells Replenish Neural Lineages in Alzheimer’s Disease Mice via CXCR4/SDF-1 Chemotaxis
【24h】

G-CSF-mobilized Bone Marrow Mesenchymal Stem Cells Replenish Neural Lineages in Alzheimer’s Disease Mice via CXCR4/SDF-1 Chemotaxis

机译:G-CSF动员骨髓间充质干细胞通过CXCR4 / SDF-1趋化性补充阿尔茨海默病小鼠的神经谱系

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Recent studies reported granulocyte colony-stimulating factor (G-CSF) treatment can improve the cognitive function of Alzheimer’s disease (AD) mice, and the mobilized hematopoietic stem cells (HSCs) or bone marrow mesenchymal stem cells (BM-MSCs) are proposed to be involved in this recovery effect. However, the exact role of mobilized HSC/BM-MSC in G-CSF-based therapeutic effects is still unknown. Here, we report that C-X-C chemokine receptor type 4 (CXCR4)/stromal cell-derived factor 1 (SDF-1) chemotaxis was a key mediator in G-CSF-based therapeutic effects, which was involved in the recruitment of repair-competent cells. Furthermore, we found both mobilized HSCs and BM-MSCs were able to infiltrate into the brain, but only BM-MSCs replenished the neural lineage cells and contributed to neurogenesis in the brains of AD mice. Together, our data show that mobilized BM-MSCs are involved in the replenishment of neural lineages following G-CSF treatment via CXCR4/SDF-1 chemotaxis and further support the potential use of BM-MSCs for further autogenically therapeutic applications.
机译:摘要最近的研究报告了粒细胞菌落刺激因子(G-CSF)治疗可以改善阿尔茨海默病(Ad)小鼠的认知功能,并提出了动员的造血干细胞(HSC)或骨髓间充质干细胞(BM-MSCs)参与这种恢复效果。然而,动员HSC / BM-MSC在基于G-CSF的治疗效果中的确切作用仍然未知。在此,我们报告CXC趋化因子受体类型4(CXCR4)/基质细胞衍生因子1(SDF-1)趋化性是基于G-CSF的治疗效果中的关键介体,其参与招募态性细胞的募集。此外,我们发现动员的HSC和BM-MSCs能够渗入大脑,但只有BM-MSCs补充神经谱系细胞并导致广告小鼠的大脑中的神经发生。我们的数据显示,动员的BM-MSCs参与通过CXCR4 / SDF-1趋化性治疗G-CSF处理后的神经谱系的补充,并进一步支持BM-MSC的潜在使用以进行进一步的自肠治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号